N. Hutnick

发表

Adenovirus-Specific Immunity Following Immunization with an Ad5 HIV-1 Vaccine Candidate in Humans

M. Betts, M. Lifton, J. Shiver, 2009, Nature Medicine.

Co-Administration of Molecular Adjuvants Expressing NF-Kappa B Subunit p65/RelA or Type-1 Transactivator T-bet Enhance Antigen Specific DNA Vaccine-Induced Immunity

D. Weiner, S. Kudchodkar, K. Ugen, 2014, Vaccines.

DNA vaccine cocktail expressing genotype A and C HBV surface and consensus core antigens generates robust cytotoxic and antibody responses in mice and Rhesus macaques

N. Obeng-Adjei, M. Morrow, N. Hutnick, 2013, Cancer Gene Therapy.

Daratumumab Plus Atezolizumab in Previously Treated Advanced or Metastatic NSCLC: Brief Report on a Randomized, Open-Label, Phase 1b/2 Study (LUC2001 JNJ-54767414)

S. Ramalingam, R. Knoblauch, C. Moy, 2020, JTO clinical and research reports.

Exercise and lymphocyte activation following chemotherapy for breast cancer.

W. Kraemer, A. Mastro, E. Orsega-Smith, 2005, Medicine and science in sports and exercise.

Inducing Humoral and Cellular Responses to Multiple Sporozoite and Liver-Stage Malaria Antigens Using Exogenous Plasmid DNA

N. Sardesai, D. Weiner, Jian Yan, 2013, Infection and Immunity.

DNA vaccines targeting heavy chain C-terminal fragments of Clostridium botulinum neurotoxin serotypes A, B, and E induce potent humoral and cellular immunity and provide protection from lethal toxin challenge

N. Sardesai, D. Weiner, Jian Yan, 2015, Human vaccines & immunotherapeutics.

Intradermal DNA vaccination enhanced by low-current electroporation improves antigen expression and induces robust cellular and humoral immune responses.

D. Weiner, Jian Yan, B. Ferraro, 2012, Human gene therapy.

An optimized SIV DNA vaccine can serve as a boost for Ad5 and provide partial protection from a high-dose SIVmac251 challenge.

Christopher J. Miller, N. Sardesai, J. Kim, 2012, Vaccine.

Vaccination with Ad5 Vectors Expands Ad5-Specific CD8+ T Cells without Altering Memory Phenotype or Functionality

M. Betts, H. Ertl, D. Carnathan, 2010, PloS one.

Abstract 1710: Providing confidence around computational tissue analysis using heterogeneity assessments

F. Aeffner, D. Rudmann, M. Sharp, 2017 .

An Enhanced Synthetic Multiclade DNA Prime Induces Improved Cross-Clade-Reactive Functional Antibodies when Combined with an Adjuvanted Protein Boost in Nonhuman Primates

S. Zolla-Pazner, N. Sardesai, D. Weiner, 2015, Journal of Virology.

Adenovirus-specific human T cells are pervasive, polyfunctional, and cross-reactive.

M. Betts, H. Ertl, D. Carnathan, 2010, Vaccine.

Chemokine Adjuvanted Electroporated-DNA Vaccine Induces Substantial Protection from Simian Immunodeficiency Virus Vaginal Challenge

N. Sardesai, D. Weiner, M. Kutzler, 2015, Mucosal Immunology.

Adenovirus specific T-cell responses in humans following natural infection and vaccination

N. Hutnick, 2010 .

Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody.

K. Flaherty, P. O'dwyer, S. Green, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Innate Lymphoid Cells Promote Anatomical Containment of Lymphoid-Resident Commensal Bacteria

F. Bushman, D. Weiner, H. Kiyono, 2012, Science.

Clinical applications of DNA vaccines: current progress.

D. Weiner, B. Ferraro, Thomas H Shin, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Adenovirus-Based Vaccines: Comparison of Vectors from Three Species of Adenoviridae

P. Kaleebu, B. Jia, M. Betts, 2010, Journal of Virology.

Baseline Ad5 serostatus does not predict Ad5-HIV vaccine-induced expansion of Ad-specific CD4+ T-cells

M. Betts, H. Ertl, D. Carnathan, 2009, Nature Medicine.

AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells.

Etiena Basner-Tschakarjan, M. Betts, J. Kastelein, 2009, Blood.

Perforin and IL-2 Upregulation Define Qualitative Differences among Highly Functional Virus-Specific Human CD8+ T Cells

D. Dolfi, E. Wherry, M. Betts, 2010, PLoS pathogens.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, Brian D. Kelly, 2016, Journal of Immunotherapy for Cancer.

Selected approaches for increasing HIV DNA vaccine immunogenicity in vivo.

D. Weiner, C. B. Bian, K. Muthumani, 2011, Current opinion in virology.

Improvement of DNA Vaccines by Electroporation

D. Weiner, Xuefei Shen, N. Hutnick, 2012 .

Corrigendum: Baseline Ad5 serostatus does not predict Ad5 HIV vaccine–induced expansion of adenovirus-specific CD4+ T cells

M. Betts, H. Ertl, D. Carnathan, 2009, Nature Medicine.

HIV-1 Env DNA Vaccine plus Protein Boost Delivered by EP Expands B- and T-Cell Responses and Neutralizing Phenotype In Vivo

N. Sardesai, D. Weiner, Jian Yan, 2013, PloS one.

Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor)

C. Drake, P. Sharma, P. Troncoso, 2023, Journal for ImmunoTherapy of Cancer.

Chemokine Adjuvanted Electroporated-DNA Vaccine Induces Substantial Protection from Simian Immunodeficiency Virus Vaginal Challenge

N. Sardesai, D. Weiner, M. Kutzler, 2015, Mucosal Immunology.

Abstract 1727: Antitumor activity associated with dual targeting of CD38 and programmed death-1 (PD-1) pathways in preclinical models

A. Korman, R. Graziano, Natalie A. Bezman, 2018, Immunology.

Clinical applications of DNA vaccines: current progress.

D. Weiner, B. Ferraro, Thomas H Shin, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells.

M. Betts, J. Kastelein, K. High, 2009, Blood.